Stay updated on Anti-OX40 Antibody in Atopic Dermatitis Clinical Trial

Sign up to get notified when there's something new on the Anti-OX40 Antibody in Atopic Dermatitis Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Anti-OX40 Antibody in Atopic Dermatitis Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    A notice about NIH’s transition from “Artificial Intelligence” to “Super Intelligence” appears above the 403 error page.
    Difference
    1%
    Check dated 2026-10-25T13:16:54.000Z thumbnail image
  2. Check
    8 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov footer revision changed from v3.7.1 to v3.7.2.
    Difference
    0.2%
    Check dated 2026-10-18T14:11:29.000Z thumbnail image
  3. Check
    15 days ago
    Change Detected
    Summary
    The site footer revision number changes from v3.7.0 to v3.7.1; the page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-11T13:57:53.000Z thumbnail image
  4. Check
    35 days ago
    Change Detected
    Summary
    Page revision updated to v3.7.0 and older study documents/history entries were removed, reflecting a cleanup of the study record rather than changes to the study's current details.
    Difference
    19%
    Check dated 2026-09-20T20:12:35.000Z thumbnail image
  5. Check
    56 days ago
    Change Detected
    Summary
    The page update adds a new Revision: v3.6.6 line and removes the previous Revision: v3.6.5, indicating the study record was updated to a newer revision.
    Difference
    0.0%
    Check dated 2026-08-30T22:35:26.000Z thumbnail image
  6. Check
    78 days ago
    Change Detected
    Summary
    Revision label updated from v3.6.4 to v3.6.5 on the page. This marks a newer build of the study details.
    Difference
    0.0%
    Check dated 2026-08-09T08:29:28.000Z thumbnail image

Stay in the know with updates to Anti-OX40 Antibody in Atopic Dermatitis Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Anti-OX40 Antibody in Atopic Dermatitis Clinical Trial page.